Breast Cancer Blog and Resources

Managing breast cancer treatment side effects: CDK 4/6 inhibitors When you have hormone receptor-positive, HER2-negative...

CDK 4/6 inhibitor side effects, treatment length, and more Dr. Pooja Advani is a breast...

 CDK 4/6 inhibitors: Monitoring effectiveness and resistance For patients with hormone receptor-positive, HER2-negative, metastatic breast...

Dr. Sara Hurvitz, a medical oncologist and clinical research leader at Fred Hutch, recently joined...

For Triple Negative Breast Cancer (TNBC) Day, we’re revisiting our insightful “Ask the Expert” session...

Knowing your ESR1 status provides your care team with invaluable insights that can help optimize...

During Black History Month, we’re emphasizing the importance of diversity in clinical trials to help...

Navigating sexuality and intimacy after a breast cancer diagnosis can be challenging. We spoke with...